Shockwave Medical

SWAV

US82489T1043

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 01:29:52 31/05/2024 am IST			5-day change	1st Jan Change
334.8 ^USD	-0.01%		+0.01%	+75.69%

03/06	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 1000	CI
03/06	Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 400 Health Care	CI

Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from NASDAQ Composite Index

May 31, 2024

ShockWave Medical, Inc. has been removed from NASDAQ Composite Index (^COMP) Constituents .

Latest news about Shockwave Medical

Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 1000	03/06	CI
Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 400 Health Care	03/06	CI
Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P Composite 1500	03/06	CI
Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P 400	03/06	CI
Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P Healthcare Equipment Select Industry Index	03/06	CI
Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P Global BMI Index	03/06	CI
Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from S&P TMI Index	03/06	CI
Shockwave Medical, Inc. Announces Termination of Employment of Douglas Godshall as Chief Executive Officer	01/06	CI
Shockwave Medical, Inc. Announces Termination of Employment of Renee Gaeta as Chief Financial Officer	01/06	CI
Shockwave Medical, Inc. Announces Board Changes	01/06	CI
Sector Update: Health Care Stocks Advance Friday Afternoon	31/05	MT
J&J: completes acquisition of Shockwave Medical	31/05	CF
Johnson & Johnson Closes Acquisition of Shockwave Medical	31/05	MT
Johnson & Johnson Completes Acquisition of Shockwave Medical	31/05	MT
Shockwave Medical, Inc.(NasdaqGS:SWAV) dropped from NASDAQ Composite Index	31/05	CI
Johnson & Johnson completed the acquisition of Shockwave Medical, Inc. from a group of sellers.	31/05	CI
Sector Update: Health Care Stocks Mixed Pre-Bell Thursday	30/05	MT
Sector Update: Health Care	30/05	MT
Sarepta Therapeutics to Replace Shockwave Medical in S&P MidCap 400	30/05	MT
Johnson & Johnson to Buy Proteologix For $850 Million in Cash	16/05	MT
Johnson & Johnson Offering Notes to Help Fund Shockwave Medical Acquisition	13/05	MT
Shockwave Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	07/05	CI
Shockwave Medical Withdraws Earnings Guidance for the Full Year 2024	07/05	CI
Health Care Slips on Risk Bias -- Health Care Roundup	12/04	DJ
CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368	09/04	MT

Shockwave Medical, Inc. is a medical device company. The Company is primarily engaged in the development and commercialization of novel technologies that transform the care of patients with cardiovascular disease. The Company is focused on its intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular and heart valve disease. Built on a balloon catheter platform, the IVL technology uses lithotripsy to disrupt both superficial and deep vascular calcium., while minimizing soft tissue injury, and an integrated angioplasty balloon to dilate blockages at low pressures, restoring blood flow. Its Shockwave M5 IVL catheter and Shockwave M5+ IVL catheter are five-emitter catheters for use in its IVL System in medium-diameter vessels for the treatment of peripheral artery disease (PAD). Its Shockwave S4 IVL catheter is a four-emitter catheter for use in its IVL System in small-diameter vessels for the treatment of PAD.

Sector

Medical Equipment, Supplies & Distribution

Calendar

05/08/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Medical Equipment

	1st Jan change	Capi.
SHOCKWAVE MEDICAL	+75.69%	12.57B
MASIMO CORPORATION	+12.19%	6.98B
PENUMBRA, INC.	-30.47%	6.78B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.	+9.17%	5.2B
GETINGE AB	-19.77%	4.59B
APT MEDICAL INC.	+16.71%	4.15B
ASAHI INTECC CO., LTD.	-21.37%	3.83B
INARI MEDICAL, INC.	-27.62%	2.73B
SKAN GROUP AG	-1.49%	2B
NOVOCURE LIMITED	+18.08%	1.9B